Menu
Busisness
The company develops different business modalities with a national and international scope, for the introduction and commercialization of its portfolio of products, projects and services.
business models
Supply and purchase-sale
cooperative productions
Specialized scientific-technical services
technology transfers
License and/or co-development
International Economic Association Contracts
Mixed companies
Innovational projects
We have innovative projects by therapeutic area and protected by patents to establish alliances and business models.
- CIDEM-112 (JM-20): New multifunctional neuroprotective agent for the treatment of Alzheimer’s disease (AD) and other types of dementias.
- CIDEM-113 (JM-20): New multifunctional neuroprotective agent for the treatment of Parkinson’s.
- CIDEM-255: Development of an innovative combination of fixed-dose drugs for the treatment of mixed cancer pain.
- CIDEM-501-503: Antimicrobial peptides with anti-inflammatory properties and capable of evading resistance barriers in infectious environments.
Copyright © 2026 CIDEM